Selected research
Market Outlook & Growth Opportunities
Global Viral Sample Preservation Solution Market Outlook and Growth Opportunities 2026
Market perspective
The global Viral Sample Preservation Solution market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Viral Sample Preservation Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Viral Sample Preservation Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Viral Sample Preservation Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Viral Sample Preservation Solution market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Viral Sample Preservation Solution market include Shandong Chengwu Medical Products Factory, Thermo Fisher Scientific, Mole Bioscience, Jifan Biotechnology (Beijing), Hangzhou LifeReal Biotechnology, Hangzhou Jiuyang Biotechnology, Haimen Shengbang Laboratory Equipment, Longsee Biomedical and Guangdong Hybribio Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Viral Sample Preservation Solution market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Viral Sample Preservation Solution and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Viral Sample Preservation Solution sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Viral Sample Preservation Solution market size, projected growth trends, production technologies, key applications, and end-use industries.
Viral Sample Preservation Solution Segment by Company
Shandong Chengwu Medical Products Factory
Thermo Fisher Scientific
Mole Bioscience
Jifan Biotechnology (Beijing)
Hangzhou LifeReal Biotechnology
Hangzhou Jiuyang Biotechnology
Haimen Shengbang Laboratory Equipment
Longsee Biomedical
Guangdong Hybribio Biotech
Biocomma
Orient Gene
Darui Biotech
Beijing Hanbaihan Medical
Puritan Medical Products
Medline Industries
Longhorn Vaccines and Diagnostics
EKF Diagnostics Holdings
Copan Diagnostics
Cardinal Health
Biosigma
BioServUK
BIOBASE
BD
Aptaca
Viral Sample Preservation Solution Segment by Type
Inactivated
Non-inactivated
Viral Sample Preservation Solution Segment by Application
Hospital
Clinic
Others
Viral Sample Preservation Solution Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Viral Sample Preservation Solution status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Viral Sample Preservation Solution market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Viral Sample Preservation Solution significant trends, drivers, influence factors in global and regions.
6. To analyze Viral Sample Preservation Solution competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Viral Sample Preservation Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Viral Sample Preservation Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Viral Sample Preservation Solution.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Viral Sample Preservation Solution market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Viral Sample Preservation Solution industry.
Chapter 3: Detailed analysis of Viral Sample Preservation Solution manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Viral Sample Preservation Solution in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Viral Sample Preservation Solution in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
List of Tables
Table 1. Viral Sample Preservation Solution Industry Trends
Table 2. Viral Sample Preservation Solution Industry Drivers
Table 3. Viral Sample Preservation Solution Industry Opportunities and Challenges
Table 4. Viral Sample Preservation Solution Industry Restraints
Table 5. Global Viral Sample Preservation Solution Revenue by Company (US$ Million) & (2021-2026)
Table 6. Global Viral Sample Preservation Solution Revenue Share by Company (2021-2026)
Table 7. Global Viral Sample Preservation Solution Sales Volume by Company (M units) & (2021-2026)
Table 8. Global Viral Sample Preservation Solution Sales Volume Share by Company (2021-2026)
Table 9. Global Viral Sample Preservation Solution Average Price (USD/unit) of Company (2021-2026)
Table 10. Global Viral Sample Preservation Solution Company Ranking, (2024-2026) & (USD Million)
Table 11. Global Viral Sample Preservation Solution Key Company Manufacturing Base & Headquarters
Table 12. Global Viral Sample Preservation Solution Company, Product Type & Application
Table 13. Global Viral Sample Preservation Solution Company Establishment Date
Table 14. Global Company Market Concentration Ratio (CR5 and HHI)
Table 15. Global Viral Sample Preservation Solution by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025)
Table 16. Mergers & Acquisitions, Expansion
Table 17. Significant Companies of Inactivated
Table 18. Significant Companies of Non-inactivated
Table 19. Global Viral Sample Preservation Solution Sales Volume by Type 2021 VS 2025 VS 2032 (M units)
Table 20. Global Viral Sample Preservation Solution Sales Volume by Type (2021-2026) & (M units)
Table 21. Global Viral Sample Preservation Solution Sales Volume by Type (2027-2032) & (M units)
Table 22. Global Viral Sample Preservation Solution Sales Volume Share by Type (2021-2026)
Table 23. Global Viral Sample Preservation Solution Sales Volume Share by Type (2027-2032)
Table 24. Global Viral Sample Preservation Solution Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 25. Global Viral Sample Preservation Solution Sales Value by Type (2021-2026) & (US$ Million)
Table 26. Global Viral Sample Preservation Solution Sales Value by Type (2027-2032) & (US$ Million)
Table 27. Global Viral Sample Preservation Solution Sales Value Share by Type (2021-2026)
Table 28. Global Viral Sample Preservation Solution Sales Value Share by Type (2027-2032)
Table 29. Significant Companies of Hospital
Table 30. Significant Companies of Clinic
Table 31. Significant Companies of Others
Table 32. Global Viral Sample Preservation Solution Sales Volume by Application 2021 VS 2025 VS 2032 (M units)
Table 33. Global Viral Sample Preservation Solution Sales Volume by Application (2021-2026) & (M units)
Table 34. Global Viral Sample Preservation Solution Sales Volume by Application (2027-2032) & (M units)
Table 35. Global Viral Sample Preservation Solution Sales Volume Share by Application (2021-2026)
Table 36. Global Viral Sample Preservation Solution Sales Volume Share by Application (2027-2032)
Table 37. Global Viral Sample Preservation Solution Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 38. Global Viral Sample Preservation Solution Sales Value by Application (2021-2026) & (US$ Million)
Table 39. Global Viral Sample Preservation Solution Sales Value by Application (2027-2032) & (US$ Million)
Table 40. Global Viral Sample Preservation Solution Sales Value Share by Application (2021-2026)
Table 41. Global Viral Sample Preservation Solution Sales Value Share by Application (2027-2032)
Table 42. Global Viral Sample Preservation Solution Sales by Region: 2021 VS 2025 VS 2032 (M units)
Table 43. Global Viral Sample Preservation Solution Sales by Region (2021-2026) & (M units)
Table 44. Global Viral Sample Preservation Solution Sales Market Share by Region (2021-2026)
Table 45. Global Viral Sample Preservation Solution Sales by Region (2027-2032) & (M units)
Table 46. Global Viral Sample Preservation Solution Sales Market Share by Region (2027-2032)
Table 47. Global Viral Sample Preservation Solution Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 48. Global Viral Sample Preservation Solution Sales Value by Region (2021-2026) & (US$ Million)
Table 49. Global Viral Sample Preservation Solution Sales Value Share by Region (2021-2026)
Table 50. Global Viral Sample Preservation Solution Sales Value by Region (2027-2032) & (US$ Million)
Table 51. Global Viral Sample Preservation Solution Sales Value Share by Region (2027-2032)
Table 52. Global Viral Sample Preservation Solution Market Average Price (USD/unit) by Region (2021-2026)
Table 53. Global Viral Sample Preservation Solution Market Average Price (USD/unit) by Region (2027-2032)
Table 54. Global Viral Sample Preservation Solution Sales by Country: 2021 VS 2025 VS 2032 (M units)
Table 55. Global Viral Sample Preservation Solution Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 56. Global Viral Sample Preservation Solution Sales by Country (2021-2026) & (M units)
Table 57. Global Viral Sample Preservation Solution Sales Market Share by Country (2021-2026)
Table 58. Global Viral Sample Preservation Solution Sales by Country (2027-2032) & (M units)
Table 59. Global Viral Sample Preservation Solution Sales Market Share by Country (2027-2032)
Table 60. Global Viral Sample Preservation Solution Sales Value by Country (2021-2026) & (US$ Million)
Table 61. Global Viral Sample Preservation Solution Sales Value Market Share by Country (2021-2026)
Table 62. Global Viral Sample Preservation Solution Sales Value by Country (2027-2032) & (US$ Million)
Table 63. Global Viral Sample Preservation Solution Sales Value Market Share by Country (2027-2032)
Table 64. Shandong Chengwu Medical Products Factory Company Information
Table 65. Shandong Chengwu Medical Products Factory Business Overview
Table 66. Shandong Chengwu Medical Products Factory Viral Sample Preservation Solution Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 67. Shandong Chengwu Medical Products Factory Viral Sample Preservation Solution Product Portfolio
Table 68. Shandong Chengwu Medical Products Factory Recent Development
Table 69. Thermo Fisher Scientific Company Information
Table 70. Thermo Fisher Scientific Business Overview
Table 71. Thermo Fisher Scientific Viral Sample Preservation Solution Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 72. Thermo Fisher Scientific Viral Sample Preservation Solution Product Portfolio
Table 73. Thermo Fisher Scientific Recent Development
Table 74. Mole Bioscience Company Information
Table 75. Mole Bioscience Business Overview
Table 76. Mole Bioscience Viral Sample Preservation Solution Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 77. Mole Bioscience Viral Sample Preservation Solution Product Portfolio
Table 78. Mole Bioscience Recent Development
Table 79. Jifan Biotechnology (Beijing) Company Information
Table 80. Jifan Biotechnology (Beijing) Business Overview
Table 81. Jifan Biotechnology (Beijing) Viral Sample Preservation Solution Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 82. Jifan Biotechnology (Beijing) Viral Sample Preservation Solution Product Portfolio
Table 83. Jifan Biotechnology (Beijing) Recent Development
Table 84. Hangzhou LifeReal Biotechnology Company Information
Table 85. Hangzhou LifeReal Biotechnology Business Overview
Table 86. Hangzhou LifeReal Biotechnology Viral Sample Preservation Solution Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 87. Hangzhou LifeReal Biotechnology Viral Sample Preservation Solution Product Portfolio
Table 88. Hangzhou LifeReal Biotechnology Recent Development
Table 89. Hangzhou Jiuyang Biotechnology Company Information
Table 90. Hangzhou Jiuyang Biotechnology Business Overview
Table 91. Hangzhou Jiuyang Biotechnology Viral Sample Preservation Solution Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 92. Hangzhou Jiuyang Biotechnology Viral Sample Preservation Solution Product Portfolio
Table 93. Hangzhou Jiuyang Biotechnology Recent Development
Table 94. Haimen Shengbang Laboratory Equipment Company Information
Table 95. Haimen Shengbang Laboratory Equipment Business Overview
Table 96. Haimen Shengbang Laboratory Equipment Viral Sample Preservation Solution Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 97. Haimen Shengbang Laboratory Equipment Viral Sample Preservation Solution Product Portfolio
Table 98. Haimen Shengbang Laboratory Equipment Recent Development
Table 99. Longsee Biomedical Company Information
Table 100. Longsee Biomedical Business Overview
Table 101. Longsee Biomedical Viral Sample Preservation Solution Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 102. Longsee Biomedical Viral Sample Preservation Solution Product Portfolio
Table 103. Longsee Biomedical Recent Development
Table 104. Guangdong Hybribio Biotech Company Information
Table 105. Guangdong Hybribio Biotech Business Overview
Table 106. Guangdong Hybribio Biotech Viral Sample Preservation Solution Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 107. Guangdong Hybribio Biotech Viral Sample Preservation Solution Product Portfolio
Table 108. Guangdong Hybribio Biotech Recent Development
Table 109. Biocomma Company Information
Table 110. Biocomma Business Overview
Table 111. Biocomma Viral Sample Preservation Solution Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 112. Biocomma Viral Sample Preservation Solution Product Portfolio
Table 113. Biocomma Recent Development
Table 114. Orient Gene Company Information
Table 115. Orient Gene Business Overview
Table 116. Orient Gene Viral Sample Preservation Solution Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 117. Orient Gene Viral Sample Preservation Solution Product Portfolio
Table 118. Orient Gene Recent Development
Table 119. Darui Biotech Company Information
Table 120. Darui Biotech Business Overview
Table 121. Darui Biotech Viral Sample Preservation Solution Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 122. Darui Biotech Viral Sample Preservation Solution Product Portfolio
Table 123. Darui Biotech Recent Development
Table 124. Beijing Hanbaihan Medical Company Information
Table 125. Beijing Hanbaihan Medical Business Overview
Table 126. Beijing Hanbaihan Medical Viral Sample Preservation Solution Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 127. Beijing Hanbaihan Medical Viral Sample Preservation Solution Product Portfolio
Table 128. Beijing Hanbaihan Medical Recent Development
Table 129. Puritan Medical Products Company Information
Table 130. Puritan Medical Products Business Overview
Table 131. Puritan Medical Products Viral Sample Preservation Solution Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 132. Puritan Medical Products Viral Sample Preservation Solution Product Portfolio
Table 133. Puritan Medical Products Recent Development
Table 134. Medline Industries Company Information
Table 135. Medline Industries Business Overview
Table 136. Medline Industries Viral Sample Preservation Solution Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 137. Medline Industries Viral Sample Preservation Solution Product Portfolio
Table 138. Medline Industries Recent Development
Table 139. Longhorn Vaccines and Diagnostics Company Information
Table 140. Longhorn Vaccines and Diagnostics Business Overview
Table 141. Longhorn Vaccines and Diagnostics Viral Sample Preservation Solution Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 142. Longhorn Vaccines and Diagnostics Viral Sample Preservation Solution Product Portfolio
Table 143. Longhorn Vaccines and Diagnostics Recent Development
Table 144. EKF Diagnostics Holdings Company Information
Table 145. EKF Diagnostics Holdings Business Overview
Table 146. EKF Diagnostics Holdings Viral Sample Preservation Solution Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 147. EKF Diagnostics Holdings Viral Sample Preservation Solution Product Portfolio
Table 148. EKF Diagnostics Holdings Recent Development
Table 149. Copan Diagnostics Company Information
Table 150. Copan Diagnostics Business Overview
Table 151. Copan Diagnostics Viral Sample Preservation Solution Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 152. Copan Diagnostics Viral Sample Preservation Solution Product Portfolio
Table 153. Copan Diagnostics Recent Development
Table 154. Cardinal Health Company Information
Table 155. Cardinal Health Business Overview
Table 156. Cardinal Health Viral Sample Preservation Solution Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 157. Cardinal Health Viral Sample Preservation Solution Product Portfolio
Table 158. Cardinal Health Recent Development
Table 159. Biosigma Company Information
Table 160. Biosigma Business Overview
Table 161. Biosigma Viral Sample Preservation Solution Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 162. Biosigma Viral Sample Preservation Solution Product Portfolio
Table 163. Biosigma Recent Development
Table 164. BioServUK Company Information
Table 165. BioServUK Business Overview
Table 166. BioServUK Viral Sample Preservation Solution Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 167. BioServUK Viral Sample Preservation Solution Product Portfolio
Table 168. BioServUK Recent Development
Table 169. BIOBASE Company Information
Table 170. BIOBASE Business Overview
Table 171. BIOBASE Viral Sample Preservation Solution Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 172. BIOBASE Viral Sample Preservation Solution Product Portfolio
Table 173. BIOBASE Recent Development
Table 174. BD Company Information
Table 175. BD Business Overview
Table 176. BD Viral Sample Preservation Solution Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 177. BD Viral Sample Preservation Solution Product Portfolio
Table 178. BD Recent Development
Table 179. Aptaca Company Information
Table 180. Aptaca Business Overview
Table 181. Aptaca Viral Sample Preservation Solution Sales (M units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 182. Aptaca Viral Sample Preservation Solution Product Portfolio
Table 183. Aptaca Recent Development
Table 184. Key Raw Materials
Table 185. Raw Materials Key Suppliers
Table 186. Viral Sample Preservation Solution Distributors List
Table 187. Viral Sample Preservation Solution Customers List
Table 188. Research Programs/Design for This Report
Table 189. Authors List of This Report
Table 190. Secondary Sources
Table 191. Primary Sources
List of Figures
Figure 1. Viral Sample Preservation Solution Product Image
Figure 2. Global Viral Sample Preservation Solution Sales Value (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Viral Sample Preservation Solution Sales Value (2021-2032) & (US$ Million)
Figure 4. Global Viral Sample Preservation Solution Sales (2021-2032) & (M units)
Figure 5. Global Viral Sample Preservation Solution Sales Average Price (USD/unit) & (2021-2032)
Figure 6. Global Viral Sample Preservation Solution Company Revenue Ranking in 2025 (US$ Million)
Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million)
Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 9. Inactivated Image
Figure 10. Non-inactivated Image
Figure 11. Global Viral Sample Preservation Solution Sales Volume by Type (2021 VS 2025 VS 2032) & (M units)
Figure 12. Global Viral Sample Preservation Solution Sales Volume Share 2021 VS 2025 VS 2032
Figure 13. Global Viral Sample Preservation Solution Sales Volume Share by Type (2021-2032)
Figure 14. Global Viral Sample Preservation Solution Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 15. Global Viral Sample Preservation Solution Sales Value Share 2021 VS 2025 VS 2032
Figure 16. Global Viral Sample Preservation Solution Sales Value Share by Type (2021-2032)
Figure 17. Hospital Image
Figure 18. Clinic Image
Figure 19. Others Image
Figure 20. Global Viral Sample Preservation Solution Sales Volume by Application (2021 VS 2025 VS 2032) & (M units)
Figure 21. Global Viral Sample Preservation Solution Sales Volume Share 2021 VS 2025 VS 2032
Figure 22. Global Viral Sample Preservation Solution Sales Volume Share by Application (2021-2032)
Figure 23. Global Viral Sample Preservation Solution Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 24. Global Viral Sample Preservation Solution Sales Value Share 2021 VS 2025 VS 2032
Figure 25. Global Viral Sample Preservation Solution Sales Value Share by Application (2021-2032)
Figure 26. Global Viral Sample Preservation Solution Sales by Region: 2021 VS 2025 VS 2032 (M units)
Figure 27. Global Viral Sample Preservation Solution Sales Market Share by Region: 2021 VS 2025 VS 2032
Figure 28. Global Viral Sample Preservation Solution Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 29. Global Viral Sample Preservation Solution Sales Value Share by Region: 2021 VS 2025 VS 2032
Figure 30. North America Viral Sample Preservation Solution Sales Value (2021-2032) & (US$ Million)
Figure 31. North America Viral Sample Preservation Solution Sales Value Share by Country (%), 2025 VS 2032
Figure 32. Europe Viral Sample Preservation Solution Sales Value (2021-2032) & (US$ Million)
Figure 33. Europe Viral Sample Preservation Solution Sales Value Share by Country (%), 2025 VS 2032
Figure 34. Asia-Pacific Viral Sample Preservation Solution Sales Value (2021-2032) & (US$ Million)
Figure 35. Asia-Pacific Viral Sample Preservation Solution Sales Value Share by Country (%), 2025 VS 2032
Figure 36. South America Viral Sample Preservation Solution Sales Value (2021-2032) & (US$ Million)
Figure 37. South America Viral Sample Preservation Solution Sales Value Share by Country (%), 2025 VS 2032
Figure 38. Middle East & Africa Viral Sample Preservation Solution Sales Value (2021-2032) & (US$ Million)
Figure 39. Middle East & Africa Viral Sample Preservation Solution Sales Value Share by Country (%), 2025 VS 2032
Figure 40. USA Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 41. USA Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 42. USA Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 43. Canada Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 44. Canada Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 45. Canada Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 46. Mexico Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 47. Mexico Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 48. Mexico Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 49. Germany Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 50. Germany Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 51. Germany Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 52. France Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 53. France Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 54. France Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 55. U.K. Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 56. U.K. Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 57. U.K. Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 58. Italy Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 59. Italy Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 60. Italy Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 61. Spain Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 62. Spain Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 63. Spain Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 64. Russia Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 65. Russia Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 66. Russia Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 67. Netherlands Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 68. Netherlands Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 69. Netherlands Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 70. Nordic Countries Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 71. Nordic Countries Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 72. Nordic Countries Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 73. China Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 74. China Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 75. China Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 76. Japan Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 77. Japan Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 78. Japan Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 79. South Korea Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 80. South Korea Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 81. South Korea Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 82. India Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 83. India Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 84. India Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 85. Australia Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 86. Australia Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 87. Australia Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 88. Southeast Asia Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 89. Southeast Asia Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 90. Southeast Asia Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 91. Brazil Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 92. Brazil Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 93. Brazil Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 94. Argentina Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 95. Argentina Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 96. Argentina Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 97. Chile Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 98. Chile Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 99. Chile Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 100. Colombia Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 101. Colombia Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 102. Colombia Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 103. Peru Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 104. Peru Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 105. Peru Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 106. Saudi Arabia Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 107. Saudi Arabia Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 108. Saudi Arabia Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 109. Israel Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 110. Israel Arabia Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 111. Israel Arabia Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 112. UAE Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 113. UAE Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 114. UAE Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 115. Turkey Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 116. Turkey Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 117. Turkey Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 118. Iran Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 119. Iran Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 120. Iran Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 121. Egypt Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 122. Egypt Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 123. Egypt Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 124. Viral Sample Preservation Solution Value Chain
Figure 125. Manufacturing Cost Structure
Figure 126. Viral Sample Preservation Solution Sales Mode & Process
Figure 127. Direct Comparison with Distribution Share
Figure 128. Distributors Profiles
Figure 129. Years Considered
Figure 130. Research Process
Figure 131. Key Executives Interviewed
Scope & coverage.
Types
- Inactivated
- Non-inactivated
Applications
- Hospital
- Clinic
- Others
Companies covered
- Shandong Chengwu Medical Products Factory
- Thermo Fisher Scientific
- Mole Bioscience
- Jifan Biotechnology (Beijing)
- Hangzhou LifeReal Biotechnology
- Hangzhou Jiuyang Biotechnology
- Haimen Shengbang Laboratory Equipment
- Longsee Biomedical
- Guangdong Hybribio Biotech
- Biocomma
- Orient Gene
- Darui Biotech
- Beijing Hanbaihan Medical
- Puritan Medical Products
- Medline Industries
- Longhorn Vaccines and Diagnostics
- EKF Diagnostics Holdings
- Copan Diagnostics
- Cardinal Health
- Biosigma
- BioServUK
- BIOBASE
- BD
- Aptaca
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Viral Sample Preservation Solution Sales Value (2021-2032)
- 1.2.2 Global Viral Sample Preservation Solution Sales Volume (2021-2032)
- 1.2.3 Global Viral Sample Preservation Solution Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Viral Sample Preservation Solution Market Dynamics
- 2.1 Viral Sample Preservation Solution Industry Trends
- 2.2 Viral Sample Preservation Solution Industry Drivers
- 2.3 Viral Sample Preservation Solution Industry Opportunities and Challenges
- 2.4 Viral Sample Preservation Solution Industry Restraints
3 Viral Sample Preservation Solution Market by Company
- 3.1 Global Viral Sample Preservation Solution Company Revenue Ranking in 2025
- 3.2 Global Viral Sample Preservation Solution Revenue by Company (2021-2026)
- 3.3 Global Viral Sample Preservation Solution Sales Volume by Company (2021-2026)
- 3.4 Global Viral Sample Preservation Solution Average Price by Company (2021-2026)
- 3.5 Global Viral Sample Preservation Solution Company Ranking (2024-2026)
- 3.6 Global Viral Sample Preservation Solution Company Manufacturing Base and Headquarters
- 3.7 Global Viral Sample Preservation Solution Company Product Type and Application
- 3.8 Global Viral Sample Preservation Solution Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Viral Sample Preservation Solution Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Viral Sample Preservation Solution Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Viral Sample Preservation Solution Market by Type
- 4.1 Viral Sample Preservation Solution Type Introduction
- 4.1.1 Inactivated
- 4.1.2 Non-inactivated
- 4.2 Global Viral Sample Preservation Solution Sales Volume by Type
- 4.2.1 Global Viral Sample Preservation Solution Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Viral Sample Preservation Solution Sales Volume by Type (2021-2032)
- 4.2.3 Global Viral Sample Preservation Solution Sales Volume Share by Type (2021-2032)
- 4.3 Global Viral Sample Preservation Solution Sales Value by Type
- 4.3.1 Global Viral Sample Preservation Solution Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Viral Sample Preservation Solution Sales Value by Type (2021-2032)
- 4.3.3 Global Viral Sample Preservation Solution Sales Value Share by Type (2021-2032)
5 Viral Sample Preservation Solution Market by Application
- 5.1 Viral Sample Preservation Solution Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Others
- 5.2 Global Viral Sample Preservation Solution Sales Volume by Application
- 5.2.1 Global Viral Sample Preservation Solution Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Viral Sample Preservation Solution Sales Volume by Application (2021-2032)
- 5.2.3 Global Viral Sample Preservation Solution Sales Volume Share by Application (2021-2032)
- 5.3 Global Viral Sample Preservation Solution Sales Value by Application
- 5.3.1 Global Viral Sample Preservation Solution Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Viral Sample Preservation Solution Sales Value by Application (2021-2032)
- 5.3.3 Global Viral Sample Preservation Solution Sales Value Share by Application (2021-2032)
6 Viral Sample Preservation Solution Regional Sales and Value Analysis
- 6.1 Global Viral Sample Preservation Solution Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Viral Sample Preservation Solution Sales by Region (2021-2032)
- 6.2.1 Global Viral Sample Preservation Solution Sales by Region: 2021-2026
- 6.2.2 Global Viral Sample Preservation Solution Sales by Region (2027-2032)
- 6.3 Global Viral Sample Preservation Solution Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Viral Sample Preservation Solution Sales Value by Region (2021-2032)
- 6.4.1 Global Viral Sample Preservation Solution Sales Value by Region: 2021-2026
- 6.4.2 Global Viral Sample Preservation Solution Sales Value by Region (2027-2032)
- 6.5 Global Viral Sample Preservation Solution Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Viral Sample Preservation Solution Sales Value (2021-2032)
- 6.6.2 North America Viral Sample Preservation Solution Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Viral Sample Preservation Solution Sales Value (2021-2032)
- 6.7.2 Europe Viral Sample Preservation Solution Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Viral Sample Preservation Solution Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Viral Sample Preservation Solution Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Viral Sample Preservation Solution Sales Value (2021-2032)
- 6.9.2 South America Viral Sample Preservation Solution Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Viral Sample Preservation Solution Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Viral Sample Preservation Solution Sales Value Share by Country, 2025 VS 2032
7 Viral Sample Preservation Solution Country-level Sales and Value Analysis
- 7.1 Global Viral Sample Preservation Solution Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Viral Sample Preservation Solution Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Viral Sample Preservation Solution Sales by Country (2021-2032)
- 7.3.1 Global Viral Sample Preservation Solution Sales by Country (2021-2026)
- 7.3.2 Global Viral Sample Preservation Solution Sales by Country (2027-2032)
- 7.4 Global Viral Sample Preservation Solution Sales Value by Country (2021-2032)
- 7.4.1 Global Viral Sample Preservation Solution Sales Value by Country (2021-2026)
- 7.4.2 Global Viral Sample Preservation Solution Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.9.2 France Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.16.2 China Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.19.2 India Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Viral Sample Preservation Solution Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Viral Sample Preservation Solution Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Viral Sample Preservation Solution Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Shandong Chengwu Medical Products Factory
- 8.1.1 Shandong Chengwu Medical Products Factory Company Information
- 8.1.2 Shandong Chengwu Medical Products Factory Business Overview
- 8.1.3 Shandong Chengwu Medical Products Factory Viral Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Shandong Chengwu Medical Products Factory Viral Sample Preservation Solution Product Portfolio
- 8.1.5 Shandong Chengwu Medical Products Factory Recent Developments
- 8.2 Thermo Fisher Scientific
- 8.2.1 Thermo Fisher Scientific Company Information
- 8.2.2 Thermo Fisher Scientific Business Overview
- 8.2.3 Thermo Fisher Scientific Viral Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Thermo Fisher Scientific Viral Sample Preservation Solution Product Portfolio
- 8.2.5 Thermo Fisher Scientific Recent Developments
- 8.3 Mole Bioscience
- 8.3.1 Mole Bioscience Company Information
- 8.3.2 Mole Bioscience Business Overview
- 8.3.3 Mole Bioscience Viral Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Mole Bioscience Viral Sample Preservation Solution Product Portfolio
- 8.3.5 Mole Bioscience Recent Developments
- 8.4 Jifan Biotechnology (Beijing)
- 8.4.1 Jifan Biotechnology (Beijing) Company Information
- 8.4.2 Jifan Biotechnology (Beijing) Business Overview
- 8.4.3 Jifan Biotechnology (Beijing) Viral Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Jifan Biotechnology (Beijing) Viral Sample Preservation Solution Product Portfolio
- 8.4.5 Jifan Biotechnology (Beijing) Recent Developments
- 8.5 Hangzhou LifeReal Biotechnology
- 8.5.1 Hangzhou LifeReal Biotechnology Company Information
- 8.5.2 Hangzhou LifeReal Biotechnology Business Overview
- 8.5.3 Hangzhou LifeReal Biotechnology Viral Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Hangzhou LifeReal Biotechnology Viral Sample Preservation Solution Product Portfolio
- 8.5.5 Hangzhou LifeReal Biotechnology Recent Developments
- 8.6 Hangzhou Jiuyang Biotechnology
- 8.6.1 Hangzhou Jiuyang Biotechnology Company Information
- 8.6.2 Hangzhou Jiuyang Biotechnology Business Overview
- 8.6.3 Hangzhou Jiuyang Biotechnology Viral Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Hangzhou Jiuyang Biotechnology Viral Sample Preservation Solution Product Portfolio
- 8.6.5 Hangzhou Jiuyang Biotechnology Recent Developments
- 8.7 Haimen Shengbang Laboratory Equipment
- 8.7.1 Haimen Shengbang Laboratory Equipment Company Information
- 8.7.2 Haimen Shengbang Laboratory Equipment Business Overview
- 8.7.3 Haimen Shengbang Laboratory Equipment Viral Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Haimen Shengbang Laboratory Equipment Viral Sample Preservation Solution Product Portfolio
- 8.7.5 Haimen Shengbang Laboratory Equipment Recent Developments
- 8.8 Longsee Biomedical
- 8.8.1 Longsee Biomedical Company Information
- 8.8.2 Longsee Biomedical Business Overview
- 8.8.3 Longsee Biomedical Viral Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Longsee Biomedical Viral Sample Preservation Solution Product Portfolio
- 8.8.5 Longsee Biomedical Recent Developments
- 8.9 Guangdong Hybribio Biotech
- 8.9.1 Guangdong Hybribio Biotech Company Information
- 8.9.2 Guangdong Hybribio Biotech Business Overview
- 8.9.3 Guangdong Hybribio Biotech Viral Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Guangdong Hybribio Biotech Viral Sample Preservation Solution Product Portfolio
- 8.9.5 Guangdong Hybribio Biotech Recent Developments
- 8.10 Biocomma
- 8.10.1 Biocomma Company Information
- 8.10.2 Biocomma Business Overview
- 8.10.3 Biocomma Viral Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.10.4 Biocomma Viral Sample Preservation Solution Product Portfolio
- 8.10.5 Biocomma Recent Developments
- 8.11 Orient Gene
- 8.11.1 Orient Gene Company Information
- 8.11.2 Orient Gene Business Overview
- 8.11.3 Orient Gene Viral Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.11.4 Orient Gene Viral Sample Preservation Solution Product Portfolio
- 8.11.5 Orient Gene Recent Developments
- 8.12 Darui Biotech
- 8.12.1 Darui Biotech Company Information
- 8.12.2 Darui Biotech Business Overview
- 8.12.3 Darui Biotech Viral Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.12.4 Darui Biotech Viral Sample Preservation Solution Product Portfolio
- 8.12.5 Darui Biotech Recent Developments
- 8.13 Beijing Hanbaihan Medical
- 8.13.1 Beijing Hanbaihan Medical Company Information
- 8.13.2 Beijing Hanbaihan Medical Business Overview
- 8.13.3 Beijing Hanbaihan Medical Viral Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.13.4 Beijing Hanbaihan Medical Viral Sample Preservation Solution Product Portfolio
- 8.13.5 Beijing Hanbaihan Medical Recent Developments
- 8.14 Puritan Medical Products
- 8.14.1 Puritan Medical Products Company Information
- 8.14.2 Puritan Medical Products Business Overview
- 8.14.3 Puritan Medical Products Viral Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.14.4 Puritan Medical Products Viral Sample Preservation Solution Product Portfolio
- 8.14.5 Puritan Medical Products Recent Developments
- 8.15 Medline Industries
- 8.15.1 Medline Industries Company Information
- 8.15.2 Medline Industries Business Overview
- 8.15.3 Medline Industries Viral Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.15.4 Medline Industries Viral Sample Preservation Solution Product Portfolio
- 8.15.5 Medline Industries Recent Developments
- 8.16 Longhorn Vaccines and Diagnostics
- 8.16.1 Longhorn Vaccines and Diagnostics Company Information
- 8.16.2 Longhorn Vaccines and Diagnostics Business Overview
- 8.16.3 Longhorn Vaccines and Diagnostics Viral Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.16.4 Longhorn Vaccines and Diagnostics Viral Sample Preservation Solution Product Portfolio
- 8.16.5 Longhorn Vaccines and Diagnostics Recent Developments
- 8.17 EKF Diagnostics Holdings
- 8.17.1 EKF Diagnostics Holdings Company Information
- 8.17.2 EKF Diagnostics Holdings Business Overview
- 8.17.3 EKF Diagnostics Holdings Viral Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.17.4 EKF Diagnostics Holdings Viral Sample Preservation Solution Product Portfolio
- 8.17.5 EKF Diagnostics Holdings Recent Developments
- 8.18 Copan Diagnostics
- 8.18.1 Copan Diagnostics Company Information
- 8.18.2 Copan Diagnostics Business Overview
- 8.18.3 Copan Diagnostics Viral Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.18.4 Copan Diagnostics Viral Sample Preservation Solution Product Portfolio
- 8.18.5 Copan Diagnostics Recent Developments
- 8.19 Cardinal Health
- 8.19.1 Cardinal Health Company Information
- 8.19.2 Cardinal Health Business Overview
- 8.19.3 Cardinal Health Viral Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.19.4 Cardinal Health Viral Sample Preservation Solution Product Portfolio
- 8.19.5 Cardinal Health Recent Developments
- 8.20 Biosigma
- 8.20.1 Biosigma Company Information
- 8.20.2 Biosigma Business Overview
- 8.20.3 Biosigma Viral Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.20.4 Biosigma Viral Sample Preservation Solution Product Portfolio
- 8.20.5 Biosigma Recent Developments
- 8.21 BioServUK
- 8.21.1 BioServUK Company Information
- 8.21.2 BioServUK Business Overview
- 8.21.3 BioServUK Viral Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.21.4 BioServUK Viral Sample Preservation Solution Product Portfolio
- 8.21.5 BioServUK Recent Developments
- 8.22 BIOBASE
- 8.22.1 BIOBASE Company Information
- 8.22.2 BIOBASE Business Overview
- 8.22.3 BIOBASE Viral Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.22.4 BIOBASE Viral Sample Preservation Solution Product Portfolio
- 8.22.5 BIOBASE Recent Developments
- 8.23 BD
- 8.23.1 BD Company Information
- 8.23.2 BD Business Overview
- 8.23.3 BD Viral Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.23.4 BD Viral Sample Preservation Solution Product Portfolio
- 8.23.5 BD Recent Developments
- 8.24 Aptaca
- 8.24.1 Aptaca Company Information
- 8.24.2 Aptaca Business Overview
- 8.24.3 Aptaca Viral Sample Preservation Solution Sales, Value and Gross Margin (2021-2026)
- 8.24.4 Aptaca Viral Sample Preservation Solution Product Portfolio
- 8.24.5 Aptaca Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Viral Sample Preservation Solution Value Chain Analysis
- 9.1.1 Viral Sample Preservation Solution Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Viral Sample Preservation Solution Sales Mode & Process
- 9.2 Viral Sample Preservation Solution Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Viral Sample Preservation Solution Distributors
- 9.2.3 Viral Sample Preservation Solution Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,250USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst